I think this article somewhat speaks for itself and why reporting is important and this is probably not the last story we will hear on this. If government had wanted to track this, a data base reporting system could have been set up with applicable laws a long time ago requiring payments to be...
This is probably a good move to speed this process up since many pharmaceutical companies have and are looking at moving more trials to India. More information can be read here about the changing face of Pharma in reference to research and development. One more area to think about too is the use...
Posted to
The Medical Quack .... by Barbara Duck
on 09-19-2008
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Cancer, clinical trials, Congress, DNA Testing, National Cancer Institute, Justice Department
Genomics is back on the list for Congress, with creating an additional new agency and a focus on collecting the necessary information to allow research and development. Also included would be guidelines and rules related to genetic and pharmacogenomic tests to bring both Pharma and medical...
Posted to
The Medical Quack .... by Barbara Duck
on 09-12-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, healthcare, Pharma, Congress, Pharmacogenomics
We all know this is one big job. We also need to bring Congress up to the 21st Century to get the job done too as we don't want the blind leading the blind. Stories in the past showed an FDA not aggressively enough seeking bigger budgets and reflecting back to a post in February, some of the top...
Discussed here is the recent law in Massachusetts relative to gifts, etc. just recently passed. Being the CEO of BIO, the biotech industry trade group, of course there's an interest in not having funds diminished, but also addresses the interest of the public. With all the recent Pharma...
The issues at hand goes back to 2006 with deviations from specifications on drugs, and now it is up to the Congress and the FDA once more. Did the FDA knowingly allow suspected drugs to continue to be sold? Ranbaxy makes a lot of different generic drugs and there’s no mention of the ones...
Congress and the Department of Justice now join the inquiry about the FDA actions investigating the alleged falsification of test records. This is where joint committees could also stand to shed some light here as both Australia and the UK are working with the FDA in reference to drug factories...